1.
Public Health England - Diabetes prevention programmes: evidence review, https://www.gov.uk/government/publications/diabetes-prevention-programmes-evidence-review, (2015).
2.
American Diabetes Association - Standards of Medical Care in Diabetes - 2017 Summary of Revisions. Diabetes Care. 40, S4–S5 (2017). https://doi.org/10.2337/dc17-S003.
3.
NICE - Type 2 diabetes: prevention in people at high risk | Guidance and guidelines, https://www.nice.org.uk/guidance/ph38.
4.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 346, 393–403 (2002). https://doi.org/10.1056/NEJMoa012512.
5.
Gillies, C.L., Abrams, K.R., Lambert, P.C., Cooper, N.J., Sutton, A.J., Hsu, R.T., Khunti, K.: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 334, 299–299 (2007). https://doi.org/10.1136/bmj.39063.689375.55.
6.
Lindstrom, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J.: The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 26, 3230–3236 (2003). https://doi.org/10.2337/diacare.26.12.3230.
7.
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A.D., Vijay, V.: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 49, 289–297 (2006). https://doi.org/10.1007/s00125-005-0097-z.
8.
Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Aunola, S., Cepaitis, Z., Moltchanov, V., Hakumaki, M., Mannelin, M., Martikkala, V., Sundvall, J., Uusitupa, M.: Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 344, 1343–1350 (2001). https://doi.org/10.1056/NEJM200105033441801.
9.
Matti Uusitupa: Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial. PLoS ONE. 4, (2009). https://doi.org/doi:  10.1371/journal.pone.0005656.
10.
Brown, J., Alwan, N.A., West, J., Brown, S., McKinlay, C.J., Farrar, D., Crowther, C.A.: Lifestyle interventions for the treatment of women with gestational diabetes. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK (1996). https://doi.org/10.1002/14651858.CD011970.pub2.
11.
Carlsson, L.M.S., Peltonen, M., Ahlin, S., Anveden, A., Bouchard, C., Carlsson, B., Jacobson, P., Lonroth, H., Maglio, C., Naslund, I., Pirazzi, C., Romeo, S., Sjoholm, K., Sjostom, E., Wedel, H., Svensson, P.-A., Sjostrom, L.: Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine. 367, 695–704 (2012). https://doi.org/10.1056/NEJMoa1112082.
12.
Tseng, E., Yeh, H.-C., Maruthur, N.M.: Metformin Use in Prediabetes Among U.S. Adults, 2005?2012. Diabetes Care. 40, 887–893 (2017). https://doi.org/10.2337/dc16-1509.
13.
Luchsinger, J.A., Ma, Y., Christophi, C.A., Florez, H., Golden, S.H., Hazuda, H., Crandall, J., Venditti, E., Watson, K., Jeffries, S., Manly, J.J., Pi-Sunyer, F.X.: Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 40, 958–965 (2017). https://doi.org/10.2337/dc16-2376.
14.
Breeze, P.R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P.J., Brunner, E., Tabak, A., Preston, L., Chilcott, J.: The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabetic Medicine. 34, 632–640 (2017). https://doi.org/10.1111/dme.13314.
15.
Fogelholm, M., Larsen, T., Westerterp-Plantenga, M., Macdonald, I., Martinez, J., Boyadjieva, N., Poppitt, S., Schlicht, W., Stratton, G., Sundvall, J., Lam, T., Jalo, E., Christensen, P., Drummen, M., Simpson, E., Navas-Carretero, S., Handjieva-Darlenska, T., Muirhead, R., Silvestre, M., Kahlert, D., Pastor-Sanz, L., Brand-Miller, J., Raben, A.: PREVIEW: Prevention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World. Design, Methods, and Baseline Participant Description of an Adult Cohort Enrolled into a Three-Year Randomised Clinical Trial. Nutrients. 9, (2017). https://doi.org/10.3390/nu9060632.
16.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 346, 393–403 (2002). https://doi.org/10.1056/NEJMoa012512.
17.
Gray, L.J., Yates, T., Troughton, J., Khunti, K., Davies, M.J.: Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised ‘Let’s Prevent Diabetes’ Trial. PLOS Medicine. 13, (2016). https://doi.org/10.1371/journal.pmed.1002078.
18.
A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let’s Prevent Diabetes cluster randomised controlled trial- ClinicalKey, https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0091743515003850.
19.
Barry, E., Roberts, S., Oke, J., Vijayaraghavan, S., Normansell, R., Greenhalgh, T.: Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. (2017). https://doi.org/10.1136/bmj.i6538.
20.
Webb, D.R., Gray, L.J., Khunti, K., Srinivasan, B., Taub, N., Campbell, S., Barnett, J., Farooqi, A., Echouffo-Tcheugui, J.B., Griffin, S.J., Wareham, N.J., Davies, M.J.: Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia. 54, 2237–2246 (2011). https://doi.org/10.1007/s00125-011-2189-2.
21.
Screening for type 2 diabetes: literature review and economic modelling. Clinical Governance: An International Journal. 12, (2007). https://doi.org/10.1108/cgij.2007.24812dae.003.
22.
Gray, L.J., Taub, N.A., Khunti, K., Gardiner, E., Hiles, S., Webb, D.R., Srinivasan, B.T., Davies, M.J.: The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Medicine. 27, 887–895 (2010). https://doi.org/10.1111/j.1464-5491.2010.03037.x.
23.
Gray, L.J., Davies, M.J., Hiles, S., Taub, N.A., Webb, D.R., Srinivasan, B.T., Khunti, K.: Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia. 55, 959–966 (2012). https://doi.org/10.1007/s00125-011-2432-x.
24.
Rajul Parikh,Annie Mathai,Shefali Parikh,G. Chandra Sekhar,Ravi Thomas: Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology.
25.
Helen C Eborall: Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ : British Medical Journal. 335, (2007). https://doi.org/doi:  10.1136/bmj.39303.723449.55.
26.
Li, R., Zhang, P., Barker, L.E., Chowdhury, F.M., Zhang, X.: Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care. 33, 1872–1894 (2010). https://doi.org/10.2337/dc10-0843.
27.
Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care- ClinicalKey, https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822717301031.
28.
Hamman, R.F., Wing, R.R., Edelstein, S.L., Lachin, J.M., Bray, G.A., Delahanty, L., Hoskin, M., Kriska, A.M., Mayer-Davis, E.J., Pi-Sunyer, X., Regensteiner, J., Venditti, B., Wylie-Rosett, J.: Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care. 29, 2102–2107 (2006). https://doi.org/10.2337/dc06-0560.
29.
Joiner, K.L., Nam, S., Whittemore, R.: Lifestyle interventions based on the diabetes prevention program delivered via eHealth: A systematic review and meta-analysis. Preventive Medicine. 100, 194–207 (2017). https://doi.org/10.1016/j.ypmed.2017.04.033.
30.
Georgios S Papaetis: Incretin-based therapies in prediabetes: Current evidence and future perspectives. World Journal of Diabetes. 5, (2014). https://doi.org/doi:  10.4239/wjd.v5.i6.817.
31.
Obesity: identification, assessment and management | Guidance and guidelines | NICE.
32.
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine. (2017). https://doi.org/10.1056/NEJMoa1614362.
33.
Gregg, E.W., Shaw, J.E.: Global Health Effects of Overweight and Obesity. New England Journal of Medicine. (2017). https://doi.org/10.1056/NEJMe1706095.
34.
A Systems Science Approach to the Obesity Epidemic and Prevention of Diabetes., https://www.youtube.com/watch?v=HrrD-Z0B7dY&feature=youtu.be&t=55s%20A%20Systems%20Science%20Approach%20to%20the%20Obesity%20Epidemic%20and%20Prevention%20of%20Diabetes., (20)AD.
35.
Carlsson, L.M.S., Peltonen, M., Ahlin, S., Anveden, A., Bouchard, C., Carlsson, B., Jacobson, P., Lonroth, H., Maglio, C., Naslund, I., Pirazzi, C., Romeo, S., Sjoholm, K., Sjostom, E., Wedel, H., Svensson, P.-A., Sjostrom, L.: Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine. 367, 695–704 (2012). https://doi.org/10.1056/NEJMoa1112082.
36.
Linda Penn: Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 8, (2013). https://doi.org/doi:  10.1371/journal.pone.0057143.
37.
Aguiar, E.J., Morgan, P.J., Collins, C.E., Plotnikoff, R.C., Young, M.D., Callister, R.: Efficacy of the Type 2 Diabetes Prevention Using LifeStyle Education Program RCT. American Journal of Preventive Medicine. 50, 353–364 (2016). https://doi.org/10.1016/j.amepre.2015.08.020.
38.
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial- ClinicalKey, https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858713702043.
39.
Linda Penn: Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 8, (2013). https://doi.org/doi:  10.1371/journal.pone.0057143.
40.
Long, G.H., Johansson, I., Rolandsson, O., Wennberg, P., Fhärm, E., Weinehall, L., Griffin, S.J., Simmons, R.K., Norberg, M.: Healthy behaviours and 10-year incidence of diabetes: A population cohort study. Preventive Medicine. 71, 121–127 (2015). https://doi.org/10.1016/j.ypmed.2014.12.013.
41.
Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care. 31, S61–S78 (2008). https://doi.org/10.2337/dc08-S061.
42.
Carter, P., Khunti, K., Davies, M.J.: Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of Nutrition and Metabolism. 2012, 1–6 (2012). https://doi.org/10.1155/2012/847202.
43.
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Xiao, J.-Z., Cao, H.-B., Liu, P.-A., Jiang, X.-G., Jiang, Y.-Y., Wang, J.-P., Zheng, H., Zhang, H., Bennett, P.H., Howard, B.V.: Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 20, 537–544 (1997). https://doi.org/10.2337/diacare.20.4.537.
44.
How to prevent type 2 diabetes in women with previous gestational diabetes? A systematic review of behavioural interventions- ClinicalKey, https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1751991817300785?returnurl=null&referrer=null.
45.
Malik, V.S., Popkin, B.M., Bray, G.A., Despres, J.-P., Willett, W.C., Hu, F.B.: Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis. Diabetes Care. 33, 2477–2483 (2010). https://doi.org/10.2337/dc10-1079.
46.
Schulze, M.B.: Sugar-Sweetened Beverages, Weight Gain, and Incidence of Type 2 Diabetes in Young and Middle-Aged Women. JAMA. 292, (2004). https://doi.org/10.1001/jama.292.8.927.
47.
Correction. Circulation. 116, e557–e557 (2007). https://doi.org/10.1161/CIRCULATIONAHA.107.187928.
48.
Malik, V.S., Pan, A., Willett, W.C., Hu, F.B.: Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 98, 1084–1102 (2013). https://doi.org/10.3945/ajcn.113.058362.
49.
Deborah F Tate: Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. The American Journal of Clinical Nutrition. 95, (2012). https://doi.org/doi:  10.3945/ajcn.111.026278.
50.
Pan, A., Sun, Q., Bernstein, A.M., Schulze, M.B., Manson, J.E., Willett, W.C., Hu, F.B.: Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. American Journal of Clinical Nutrition. 94, 1088–1096 (2011). https://doi.org/10.3945/ajcn.111.018978.
51.
Ley, S.H., Hamdy, O., Mohan, V., Hu, F.B.: Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet. 383, 1999–2007 (2014). https://doi.org/10.1016/S0140-6736(14)60613-9.
52.
Type 2 diabetes: prevention in people at high risk | Guidance and guidelines | NICE.
53.
Emily A Hu: White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. The BMJ. 344, (2012). https://doi.org/doi:  10.1136/bmj.e1454.
54.
Dagfinn Aune: Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. The BMJ. 353, (2016). https://doi.org/doi:  10.1136/bmj.i2716.
55.
Dyson, P.A., Kelly, T., Deakin, T., Duncan, A., Frost, G., Harrison, Z., Khatri, D., Kunka, D., McArdle, P., Mellor, D., Oliver, L., Worth, J.: Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine. 28, 1282–1288 (2011). https://doi.org/10.1111/j.1464-5491.2011.03371.x.
56.
Schwingshackl, L., Hoffmann, G., Lampousi, A.-M., Knüppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Schlesinger, S., Boeing, H.: Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. European Journal of Epidemiology. 32, 363–375 (2017). https://doi.org/10.1007/s10654-017-0246-y.
57.
Mann, J., Morenga, L.T., McLean, R., Swinburn, B., Mhurchu, C.N., Jackson, R., Kennedy, J., Beaglehole, R.: Dietary guidelines on trial: the charges are not evidence based. The Lancet. 388, 851–853 (2016). https://doi.org/10.1016/S0140-6736(16)31278-8.
58.
Dhingra, R., Sullivan, L., Jacques, P.F., Wang, T.J., Fox, C.S., Meigs, J.B., D’Agostino, R.B., Gaziano, J.M., Vasan, R.S.: Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community. Circulation. 116, 480–488 (2007). https://doi.org/10.1161/CIRCULATIONAHA.107.689935.
59.
Wu, Y., Zhang, D., Jiang, X., Jiang, W.: Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutrition, Metabolism and Cardiovascular Diseases. 25, 140–147 (2015). https://doi.org/10.1016/j.numecd.2014.10.004.
60.
Diff erences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study, http://ac.els-cdn.com/S2213858714701469/1-s2.0-S2213858714701469-main.pdf?_tid=41970bbc-7e93-11e7-a8e5-00000aab0f01&acdnat=1502455838_1e4678aef6e5b79c43c42f6b68f370f1.
61.
Aune, D., Norat, T., Romundstad, P., Vatten, L.J.: Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies. European Journal of Epidemiology. 28, 845–858 (2013). https://doi.org/10.1007/s10654-013-9852-5.
62.
Colberg, S.R., Sigal, R.J., Fernhall, B., Regensteiner, J.G., Blissmer, B.J., Rubin, R.R., Chasan-Taber, L., Albright, A.L., Braun, B.: Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 33, 2692–2696 (2010). https://doi.org/10.2337/dc10-1548.
63.
Yates, T., Wilmot, E.G., Khunti, K., Biddle, S., Gorely, T., Davies, M.J.: Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Research and Clinical Practice. 93, 292–294 (2011). https://doi.org/10.1016/j.diabres.2011.03.023.
64.
Steven N Blair: Physical inactivity: the biggest public health problem of the 21st century. British Journal of Sports Medicine. 43, 1–2 (2009).
65.
Laaksonen, D.E., Lindstrom, J., Lakka, T.A., Eriksson, J.G., Niskanen, L., Wikstrom, K., Aunola, S., Keinanen-Kiukaanniemi, S., Laakso, M., Valle, T.T., Ilanne-Parikka, P., Louheranta, A., Hamalainen, H., Rastas, M., Salminen, V., Cepaitis, Z., Hakumaki, M., Kaikkonen, H., Harkonen, P., Sundvall, J., Tuomilehto, J., Uusitupa, M.: Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study. Diabetes. 54, 158–165 (2005). https://doi.org/10.2337/diabetes.54.1.158.
66.
Thomas Yates: Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Family Practice. 13, (2012). https://doi.org/doi:  10.1186/1471-2296-13-46.
67.
Colberg, S.R., Sigal, R.J., Yardley, J.E., Riddell, M.C., Dunstan, D.W., Dempsey, P.C., Horton, E.S., Castorino, K., Tate, D.F.: Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 39, 2065–2079 (2016). https://doi.org/10.2337/dc16-1728.
68.
Stefan, N., Staiger, H., Wagner, R., Machann, J., Schick, F., H?ring, H.-U., Fritsche, A.: A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia. 58, 2877–2884 (2015). https://doi.org/10.1007/s00125-015-3760-z.
69.
Less Sitting, More Physical Activity, or Higher Fitness?- ClinicalKey, https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/playContent/1-s2.0-S0025619615006308?returnurl=null&referrer=null.
70.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey, https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126.
71.
LaMonte, M.J.: Physical activity and diabetes prevention. Journal of Applied Physiology. 99, 1205–1213 (2005). https://doi.org/10.1152/japplphysiol.00193.2005.
72.
Church, T.S., Blair, S.N., Cocreham, S., Johannsen, N., Johnson, W., Kramer, K., Mikus, C.R., Myers, V., Nauta, M., Rodarte, R.Q., Sparks, L., Thompson, A., Earnest, C.P.: Effects of Aerobic and Resistance Training on Hemoglobin A                              Levels in Patients With Type 2 Diabetes. JAMA. 304, (2010). https://doi.org/10.1001/jama.2010.1710.
73.
Orozco, L.J., Buchleitner, A.M., Gimenez-Perez, G., Roqué i Figuls, M., Richter, B., Mauricio, D.: Exercise or exercise and diet for preventing type 2 diabetes mellitus. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK (1996). https://doi.org/10.1002/14651858.CD003054.pub3.
74.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey, https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126.
75.
Gopalan, A., Lorincz, I.S., Wirtalla, C., Marcus, S.C., Long, J.A.: Awareness of Prediabetes and Engagement in Diabetes Risk?Reducing Behaviors. American Journal of Preventive Medicine. 49, 512–519 (2015). https://doi.org/10.1016/j.amepre.2015.03.007.
76.
Absetz, P., Oldenburg, B., Hankonen, N., Valve, R., Heinonen, H., Nissinen, A., Fogelholm, M., Talja, M., Uutela, A.: Type 2 Diabetes Prevention in the Real World: Three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care. 32, 1418–1420 (2009). https://doi.org/10.2337/dc09-0039.
77.
Ackermann, R.T., Finch, E.A., Brizendine, E., Zhou, H., Marrero, D.G.: Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine. 35, 357–363 (2008). https://doi.org/10.1016/j.amepre.2008.06.035.
78.
Sweeting, A.N., Ross, G.P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A.J., Wong, J.: Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment. Diabetes Care. 39, 75–81 (2016). https://doi.org/10.2337/dc15-0433.
79.
Koivusalo, S.B., Rönö, K., Klemetti, M.M., Roine, R.P., Lindström, J., Erkkola, M., Kaaja, R.J., Pöyhönen-Alho, M., Tiitinen, A., Huvinen, E., Andersson, S., Laivuori, H., Valkama, A., Meinilä, J., Kautiainen, H., Eriksson, J.G., Stach-Lempinen, B.: Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). Diabetes Care. 39, 24–30 (2016). https://doi.org/10.2337/dc15-0511.
80.
Nathan, D.M., Davidson, M.B., DeFronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., Zinman, B.: Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care. Diabetes Care. 30, 753–759 (2007). https://doi.org/10.2337/dc07-9920.
81.
Vita, P., Cardona-Morrell, M., Bauman, A., Singh, M.F., Moore, M., Pennock, R., Snow, J., Williams, M., Jackson, L., Milat, A., Colagiuri, S.: Type 2 diabetes prevention in the community: 12-Month outcomes from the Sydney Diabetes Prevention Program. Diabetes Research and Clinical Practice. 112, 13–19 (2016). https://doi.org/10.1016/j.diabres.2015.11.010.
82.
Breeze, P.R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P., Brunner, E., Tabak, A., Preston, L., Chilcott, J.: Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK. Diabetic Medicine. 34, 1136–1144 (2017). https://doi.org/10.1111/dme.13349.
83.
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 35, 723–730 (2012). https://doi.org/10.2337/dc11-1468.
84.
Bailey, Stephen: Academic Writing : A Handbook for International Students.
85.
Creme, P., Lea, M.R.: Writing At University: A Guide For Students. McGraw-Hill Education, Maidenhead (2008).